Altria (MO) Earnings: Q3 2026 Results and Next Report Date

The quarter ended September 30, 2026 and Altria published the results on October 29, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Altria reports EPS two ways: GAAP, under the accounting rules every US filer follows, and adjusted diluted EPS, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Revenue on this page is Altria's net revenues, which include excise taxes. Revenues net of excise taxes were $5,441 million, up 3.6%.
• Since Q1 2026 Altria reports e-vapor (NJOY) inside All Other, no longer as its own segment, with prior periods recast. All Other also includes Horizon and Helix International.
• Earnings include Altria's equity-method share of Anheuser-Busch InBev (ABI), in which it held an approximate 8.1% interest at September 30, 2026.

Source: Altria Q3 2026 results, October 29, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How Altria splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• Altria's Smokeable Products revenue was $5.4 billion in Q3 2026, up 1% from $5.4 billion in Q3 2025, 89% of total revenue.
• Altria's Oral Tobacco Products revenue was $688 million in Q3 2026, flat on $689 million in Q3 2025, 11% of total revenue.
• Altria's All Other revenue was $12.0 million in Q3 2026, under 1% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

In its Q3 2026 release, Altria said:

“We expect our 2026 full-year adjusted diluted EPS to be in a range of $5.66 to $5.74, representing a growth rate of 4.5% to 6.0% from a base of $5.42 in 2025.”

“As a result, we do not provide a corresponding GAAP measure for, or reconciliation to, our adjusted diluted EPS guidance.”

Source: Altria Q3 2026 release, Oct 29, 2026.

This is the company's own guidance as of Oct 29, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the MO forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

Net revenues (including excise taxes) and reported diluted EPS, each as first reported in that quarter's release.

Altria's next report is expected around January 28, 2027, a date estimated from its reporting history that the company has not yet confirmed. This page will show Q3 2026 until those results are out and have been checked against the release.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Oct 29, 2026

Altria's revenue is mostly cigarettes. Smokeable products (Marlboro and other cigarettes, plus Black & Mild cigars) had net revenues of $5,432 million of the $6,132 million total in Q3 2026. Oral tobacco products (Copenhagen, Skoal and on! nicotine pouches) had $688 million, and all other, which includes NJOY e-vapor, $12 million. (Altria Q3 2026 release, Oct 29, 2026; Altria Form 10-Q, Q3 2026, Oct 29, 2026)

Net revenues include excise taxes, which were $691 million in the quarter against $821 million a year earlier. Revenues net of excise taxes rose 3.6% to $5,441 million while net revenues rose 1.0%. Substantially all of Altria's revenue comes from the United States, and in 2025 one customer accounted for approximately 23% of consolidated net revenues and another for approximately 19%. (Altria Q3 2026 release, Oct 29, 2026; Altria Form 10-K, 2025, Feb 25, 2026)

Altria said smokeable net revenues rose 0.8% on higher pricing, partly offset by higher promotional investments, lower shipment volume and a shift toward discount brands. Domestic cigarette shipments fell 2.9% to 15,725 million sticks; Marlboro fell 6.4% to 13,324 million while discount brands rose 40.5% to 1,704 million. Altria estimates total domestic cigarette industry volume fell about 5% after adjusting for trade inventory movements. (Altria Q3 2026 release, Oct 29, 2026)

In oral tobacco, net revenues fell 0.1% as lower volume and promotions mostly offset higher pricing. Shipments fell 4.3% to 170.6 million cans: Copenhagen fell 10.1% and Skoal 12.6%, while on! rose 13.3% to 47.8 million cans. Nicotine pouches were 61.2% of the oral tobacco category, and on! held 13.5% of the pouch category, down 1.3 share points from a year earlier. (Altria Q3 2026 release, Oct 29, 2026)

Altria also makes cigarettes under contract for third parties that sell them outside the U.S. Those contract manufactured export shipments were 1,595 million sticks in Q3 2026, against 311 million a year earlier. (Altria Q3 2026 release, Oct 29, 2026)

Altria's reported diluted EPS was $1.51 in Q3 2026 and adjusted diluted EPS $1.52, a gap of one cent. Adjusted EPS excludes special items: $0.01 for tobacco and health and certain other litigation items, $0.01 for amortization of intangibles, $0.01 of income tax items and a $0.02 benefit from ABI-related special items, mainly mark-to-market gains on ABI financial instruments. Altria said the rise in both figures came from higher operating companies income and higher earnings from its ABI investment. (Altria Q3 2026 release, Oct 29, 2026)

Altria's income from investments in equity securities, mainly ABI, was $242 million in the quarter, against $107 million a year earlier. The reported effective tax rate was 23.6%, up 0.8 points, and the adjusted rate 23.0%. (Altria Q3 2026 release, Oct 29, 2026; Altria Form 10-Q, Q3 2026, Oct 29, 2026)

Weighted-average diluted shares fell 0.7% to 1,669 million. Altria repurchased 5.9 million shares at an average of $68.52 for $400 million in the quarter and paid $1.7 billion of dividends. Its board added $1 billion to the buyback program, which now runs to December 31, 2027, and the annualized dividend rate is $4.44 per share after a 4.7% increase in August. (Altria Q3 2026 release, Oct 29, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Altria gives a full-year adjusted diluted EPS range and raised it with Q3 2026 results to $5.66 to $5.74, growth of 4.5% to 6.0% from $5.42 in 2025. It does not give a revenue outlook or a GAAP EPS forecast, saying it cannot estimate special items on a forward-looking basis. (Altria Q3 2026 release, Oct 29, 2026)

Altria said the range assumes moderated e-vapor industry growth affecting combustible and e-vapor volumes, increased macroeconomic uncertainty for adult nicotine consumers, investment in contract manufacturing, that NJOY ACE does not return to the market in 2026, reinvestment of Optimize & Accelerate cost savings, and investment in its Vision. (Altria Q3 2026 release, Oct 29, 2026)

A consensus figure is the average of the models published by the analysts who cover Altria, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Altria's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning MO is on is MO a buy or a sell?, what analysts expect next is on the MO forecast, and what the company does is on the Altria (MO) stock page.

Every number on this page can be traced to a document Altria published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.